Xgrast 300 mcg Injection

Manufactured byEmcure Pharmaceuticals Ltd.
ContainsFilgrastim
OFFER
Get 25% OFF!
Valid on prescription medicines, only for first time user
PRACTO
PRACTO
COPY CODE
Description

Xgrast 300 mcg Injection is a human granulocyte colony-stimulating factor (G-CSF) analog. It stimulates the growth of white blood cells and helps in decreasing the chances of infection in patients who are undergoing chemotherapy procedures for cancer. Patients with blood disorders are advised not to use this medicine.

Side effects

Major & minor side effects for Xgrast 300 mcg Injection

  • Stomach pain
  • Hair loss
  • Constipation
  • Nausea or Vomiting
  • Fever and chills
  • Bone pain
  • Loss of appetite
  • Weight loss
  • Swelling or inflammation of mouth

Uses of Xgrast 300 mcg Injection

What is it prescribed for?

  • Neutropenia caused by chemotherapy
  • Bone Marrow Transplantation
  • Peripheral Progenitor Cell Transplantation
  • Chronic Neutropenia
  • Neutropenia caused by radiation
Read More
Concerns

Commonly asked questions

  • Onset of action
    The amount of time required for this medicine to show its effect is 1 to 3 days.
  • Duration of effect
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Safe with alcohol?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is it habit forming?
    No habit forming tendency has been reported.
  • Usage in pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.
  • Usage while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to Xgrast 300 mcg Injection and pegfilgrastim products.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.
General warnings

Splenic Rupture

This medicine should be used with caution due to the increased risk of splenic rupture. Patients having abdominal and/or shoulder tip pain while taking this medicine should consult the doctor immediately. Your doctor may advise you to stop the medicine based on your clinical condition.

Acute Respiratory Distress Syndrome (ARDS)

This medicine has been shown to cause Acute respiratory distress syndrome in rare cases. Discuss the risks and benefits with your doctor before taking this medicine. Report any symptoms of fever or respiratory distress to the doctor on priority. Replacement with a suitable alternative might be required based on the clinical condition.

Sickle cell crisis

This medicine not recommended for use in patients with a known history of sickle cell disease due to the increased risk of serious and life threatening reactions. Discuss the risks and benefits with your doctor before taking this medicine. Replacement with a suitable alternative might be required based on the clinical condition.

Missed Dose

If a dose of Xgrast 300 mcg Injection is missed, take the dose as soon as you remember. If it is almost the time for the next dose, skip the missed dose and take the next dose. Do not double the dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Cisplatin

Fluorouracil

Doxorubicin

Disease interactions

Glomerulonephritis

This medicine should be used with caution in patients with Renal dysfunction due to the increased risk of glomerulonephritis. Report to the doctor any symptoms such as swelling of ankles and face, blood in the urine, dark colored urine, or decreased urine output immediately. An alternative treatment option should be considered based on the clinical condition of the patient.

Myeloid Tumors

This medicine should be used with caution in patients with Myeloid tumors due to the increased risk of tumor growth. Report to the doctor all your medical conditions before taking this medicine.

Leukocytosis

This medicine should be used with caution in patients with Leukocytosis due to the increased risk of excessive white blood cell count. Appropriate dose adjustments or replacement with an alternative medicine should be done under your doctor's supervision.
Food interactions
Information not available.
Lab interactions
Information not available.
Do not use Xgrast 300 mcg Injection for any conditions other than those specified by the doctor. Report to the doctor all your medical conditions and current medicines before taking this medication. Report any undesired effects or lack of improvement to the doctor on priority.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine works by stimulating the production of white blood cells and thus helps to fight against infections.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Colony stimulating factors

Schedule

N/A

[Internet]. 2017 [cited 19 July 2017]. Available from:

https://www.medicines.org.uk/emc/medicine/27485

DailyMed - filgrastim injection, solution [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 19 July 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3bc802bd-76b4-4f45-8571-a436ec26228e

Filgrastim - DrugBank [Internet]. Drugbank.ca. 2017 [cited 19 July 2017]. Available from:

https://www.drugbank.ca/drugs/DB00099

Prescribing medicines in pregnancy database [Internet]. Therapeutic Goods Administration (TGA). 2017 [cited 19 July 2017]. Available from:

http://www.tga.gov.au/prescribing-medicines-pregnancy-database
Loading related questions...

How will this medicine affect me?

Chat with verified doctors starting @ ₹99
Chat now

Book a doctor

Chat with verified doctors starting @ ₹99
Book now
Something doesn’t feel right?
Report an error